Ubs Group Ag Clear Point Neuro, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 360,705 shares of CLPT stock, worth $5.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

360,705

Previous 155,410 132.1%

Holding current value

$5.59 Million

Previous $1.86 Million 323.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$10.0 - $21.79 $2.05 Million - $4.47 Million	205,295 Added 132.1%	360,705 $7.86 Million
Q2 2025 Aug 14, 2025	BUY	$10.51 - $14.71 $631,997 - $884,556	60,133 Added 63.11%	155,410 $1.86 Million
Q1 2025 May 13, 2025	BUY	$11.89 - $18.8 $583,751 - $923,004	49,096 Added 106.31%	95,277 $1.13 Million
Q4 2024 Feb 14, 2025	BUY	$10.74 - $16.68 $163,387 - $253,752	15,213 Added 49.12%	46,181 $710,000
Q3 2024 Nov 14, 2024	BUY	$5.3 - $13.18 $10,181 - $25,318	1,921 Added 6.61%	30,968 $347,000
Q2 2024 Aug 13, 2024	SELL	$5.25 - $6.73 $120,613 - $154,615	-22,974 Reduced 44.16%	29,047 $156,000
Q1 2024 May 13, 2024	SELL	$6.03 - $7.86 $9,105 - $11,868	-1,510 Reduced 2.82%	52,021 $353,000
Q4 2023 Feb 09, 2024	BUY	$4.46 - $7.07 $62,252 - $98,683	13,958 Added 35.27%	53,531 $363,000
Q3 2023 Nov 09, 2023	SELL	$5.01 - $7.09 $19,979 - $28,274	-3,988 Reduced 9.15%	39,573 $198,000
Q2 2023 Aug 11, 2023	BUY	$6.54 - $10.58 $72,090 - $116,623	11,023 Added 33.88%	43,561 $315,000
Q1 2023 May 12, 2023	BUY	$7.33 - $10.63 $2,015 - $2,923	275 Added 0.85%	32,538 $274,000
Q4 2022 Feb 08, 2023	SELL	$7.7 - $11.21 $38,500 - $56,050	-5,000 Reduced 13.42%	32,263 $273,000
Q3 2022 Nov 10, 2022	BUY	$9.82 - $16.49 $345,241 - $579,738	35,157 Added 1669.37%	37,263 $386,000
Q2 2022 Aug 10, 2022	SELL	$7.09 - $13.65 $24,432 - $47,037	-3,446 Reduced 62.07%	2,106 $27,000
Q1 2022 May 16, 2022	SELL	$7.8 - $11.6 $136,149 - $202,478	-17,455 Reduced 75.87%	5,552 $59,000
Q4 2021 Feb 14, 2022	BUY	$11.08 - $18.86 $29,040 - $49,432	2,621 Added 12.86%	23,007 $258,000
Q3 2021 Nov 15, 2021	BUY	$16.58 - $22.25 $22,051 - $29,592	1,330 Added 6.98%	20,386 $362,000
Q2 2021 Aug 13, 2021	BUY	$17.23 - $22.77 $80,119 - $105,880	4,650 Added 32.28%	19,056 $364,000
Q1 2021 May 12, 2021	BUY	$15.19 - $29.0 $22,860 - $43,645	1,505 Added 11.67%	14,406 $305,000
Q4 2020 Feb 11, 2021	BUY	$5.11 - $15.89 $38,314 - $119,143	7,498 Added 138.77%	12,901 $205,000
Q3 2020 Nov 12, 2020	BUY	$3.19 - $5.89 $17,216 - $31,788	5,397 Added 89950.0%	5,403 $30,000
Q1 2020 May 01, 2020	BUY	$3.33 - $6.14 $19 - $36	6 New	6 $0

Others Institutions Holding CLPT

# of Institutions

115

Shares Held

8.86M

Call Options Held

360K

Put Options Held

151K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $379M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account